Search

everythinglearnresearchcommunity

for

Search:↓

The cause of Frontal fibrosing alopecia, a type of hair loss, is complex, likely involving immune responses and genetics, but is not fully understood.

New cancer treatments are less harmful to hair but can still cause hair loss, color, shape, and growth changes.

Hair loss in men may be caused by inflammation triggered by hormones, and treatments reducing inflammation could potentially promote hair growth.

The scalp fat tissue of men with hair loss shows changes in gene activity that may contribute to their condition.

Activating TRPV3 reduces skin oil production and increases inflammation, potentially causing dry skin issues.

Delta opioid receptors help regulate touch sensation by reducing neurotransmitter release in the spinal cord.

PPARγ is crucial for skin health but can have both beneficial and harmful effects.

DHEA affects various tissues by interacting with multiple receptors and can be converted into sex hormones.

Sex hormones may affect COVID-19 severity, with estrogen possibly reducing risk and testosterone potentially increasing it.

δ-GABAA receptors affect alcohol consumption based on the estrous cycle and influence movement regardless of the cycle.

The document concludes that blocking the internal pathways that create androgens might help treat cancers that depend on sex hormones.

Leptin-deficient mice, used as a model for Type 2 Diabetes, have delayed wound healing due to impaired contraction and other dysfunctional cellular responses.

TRPV4 helps cells repair tissue and reduce scarring by controlling calcium levels.

EGFR and mTOR inhibitors may help manage Olmsted syndrome symptoms.

Testosterone is crucial for development, growth, and various body functions in mammals.

The book is a valuable reference on androgenic disorders for professionals but not suitable for laypeople or medical students.

Using two drugs together, Flutamide and 4-MA, is more effective for blocking male hormones than using each one alone.

The conclusion is that endocrinology significantly impacts medicine with various common medications used for treatment.

Smoking harms the skin, causing early aging and increasing cancer risk, but stopping smoking can improve skin health.

Losartan can cause temporary loss of taste.

GMG-43AC may help reduce unwanted hair growth and treat certain hair loss conditions.

Some breast cancer patients on hormone therapy experience hair loss, and treatments like certain topical inhibitors and supplements may help without harming their cancer prognosis.

Cancer treatments can cause skin-related side effects that may affect patient quality of life and require changes in treatment.

Targeted therapies for lung cancer are effective but require careful management of side effects to benefit patients.

Monocyclic aromatic compounds are important for developing various drugs and treatments.

The model and estimator can predict drug exposure in kidney transplant patients well.

Hair loss in women may have multiple causes, and eyebrow regrowth possible with specific injections.

Cancer treatments targeting specific cells and the immune system can cause skin, mouth, hair, and nail problems, affecting patients' quality of life and treatment adherence.

Vitamin D has potential benefits for cancer prevention, heart health, diabetes, obesity, muscle function, skin health, and immune function, but clinical results are mixed and more research is needed.

Blocking the Wnt pathway could lead to new treatments for cancer and tissue repair but requires careful development to avoid side effects.